Jamp-Hydralazine tablet recall in Canada: incorrect dosage
In plain language
This recall involves Jamp-Hydralazine 25 mg tablets sold in Canada. The affected lot may contain Jamp-Hydralazine 10 mg tablets instead of the labeled 25 mg tablets. Consult your healthcare provider before making any changes to your medication.
What to do
- Stop using the product immediately.
- Verify if your product is affected by checking the lot number.
- Consult your healthcare provider prior to discontinuing use or for any health concerns.
- Contact the recalling firm if you have questions about the recall.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Jamp-Hydralazine tablet
Lot: H0224009F
Why this matters
Incorrect dosage
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: H0224009F
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Incorrect dosage
What should consumers do?
Stop using the product immediately. Verify if your product is affected by checking the lot number. Consult your healthcare provider prior to discontinuing use or for any health concerns. Contact the recalling firm if you have questions about the recall.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Incorrect dosage
When was this product recalled?
This product was recalled on June 10, 2025.
Is the JAMP brand affected by this recall?
Yes, JAMP products are affected by this recall. This recall involves Jamp-Hydralazine 25 mg tablets sold in Canada. The affected lot may contain Jamp-Hydralazine 10 mg tablets instead of the labeled 25 mg tablets. Consult your healthcare provider before making any changes to your medication.